Association between extended-spectrum β-lactamase-producing Escherichia coli and oral third-generation cephalosporins

被引:0
|
作者
Hosokawa, Hiroki [1 ]
Mitsuboshi, Satoru [2 ]
Isobe, Hirokazu [3 ]
Kobayashi, Kenichi [4 ]
Moro, Hiroshi [5 ]
Kikuchi, Toshiaki [5 ]
机构
[1] Agano City Hosp, Dept Pharm, Niigata, Japan
[2] Kaetsu Hosp, Dept Pharm, Niigata, Japan
[3] Niigata Univ, Dept Pharm, Med & Dent Hosp, Niigata, Japan
[4] Nagaoka Red Cross Hosp, Dept Pharm, Niigata, Japan
[5] Niigata Univ, Dept Resp Med & Infect Dis, Grad Sch Med & Dent Sci, Niigata, Japan
来源
基金
美国国家卫生研究院;
关键词
D O I
10.1017/ice.2020.1400
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:261 / 263
页数:3
相关论文
共 50 条
  • [21] Extended-spectrum β-lactamase-encoding genes are spreading on a wide range of Escherichia coli plasmids existing prior to the use of third-generation cephalosporins
    Branger, Catherine
    Ledda, Alice
    Billard-Pomares, Typhaine
    Doublet, Benoit
    Fouteau, Stephanie
    Barbe, Valerie
    Roche, David
    Cruveiller, Stephane
    Medigue, Claudine
    Castellanos, Miguel
    Decre, Dominique
    Drieux-Rouze, Laurence
    Clermont, Olivier
    Glodt, Jeremy
    Tenaillon, Olivier
    Cloeckaert, Axel
    Arlet, Guillaume
    Denamur, Erick
    MICROBIAL GENOMICS, 2018, 4 (09):
  • [22] Risk Factors for Bloodstream Infections due to Extended-spectrum β-lactamase-producing Escherichia coli
    Wu, Un-In
    Yang, Ching-Shiang
    Chen, Wan-Chin
    Chen, Yee-Chun
    Chang, Shan-Chwen
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2010, 43 (04) : 310 - 316
  • [23] Polyclonal distribution of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Stockholm
    Titelman, E.
    Iversen, A.
    Lagergren, A.
    Kuhn, I.
    Kahlmeter, G.
    Giske, C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S90 - S91
  • [24] Extended-spectrum β-lactamase-producing organisms
    Falagas, M. E.
    Karageorgopoulos, D. E.
    JOURNAL OF HOSPITAL INFECTION, 2009, 73 (04) : 345 - 354
  • [25] Extended-spectrum β-lactamase-producing Escherichia coli (vol 20, pg 404, 2020)
    Huang, Y.
    Zeng, L.
    Doi, Y.
    Lv, L.
    Liu, J-H
    LANCET INFECTIOUS DISEASES, 2020, 20 (08): : E180 - E180
  • [26] Extended-spectrum β-lactamase-producing Escherichia coli bacteremia: Comparison of pediatric and adult populations
    Tsai, Wan-Lin
    Hung, Chih-Hsin
    Chen, Hui-An
    Wang, Jiun-Ling
    Huang, I-Fei
    Chiou, Yee-Hsuan
    Chen, Yao-Shen
    Lee, Susan Shin-Jung
    Hung, Wan-Yu
    Cheng, Ming-Fang
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2018, 51 (06) : 723 - 731
  • [27] Therapeutic Options for Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Reply
    Rodriguez-Bano, Jesus
    Pascual, Alvaro
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (01) : 120 - 121
  • [28] Epidemiology of Extended-Spectrum β-Lactamase-Producing Escherichia coli in the Human-Livestock Environment
    Nüesch-Inderbinen M.
    Stephan R.
    Current Clinical Microbiology Reports, 2016, 3 (1) : 1 - 9
  • [29] Therapeutic challenges associated with extended-spectrum, β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
    Wong-Beringer, A
    PHARMACOTHERAPY, 2001, 21 (05): : 583 - 592
  • [30] Evaluation of Antibiotics for the Treatment of Bacteremia Due to Extended-spectrum β-Lactamase-producing Escherichia coli
    Sugawara, Takafumi
    Murakami, Noritaka
    Uetake, Nobue
    Hiraki, Kouichi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2015, 135 (06): : 829 - 833